# A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Source: https://onco.cc/trials/nct07229313/  
OnCo record `nct07229313` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of KIVU-107 run by Kivu Bioscience Inc., now recruiting.

## Summary

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors is a phase 1 interventional study registered as NCT07229313 by Kivu Bioscience Inc., with 76 participants planned, started 2025-11-13. Conditions recorded: Advance Solid Tumors. Interventions recorded: KIVU-107.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07229313
- Phase: 1
- Setting: A Phase 1 Dose-Finding and Dose-Expansion Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Sponsor: Kivu Bioscience Inc.
- Enrolled: 76

## Sources

- ClinicalTrials.gov NCT07229313: https://clinicaltrials.gov/study/NCT07229313

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [KIVU-107](https://onco.cc/drugs/kivu-107/)
- companies: [Kivu Bioscience](https://onco.cc/companies/kivu-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct07229313.json